Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

116.85
Delayed Data
As of Apr 28
 +0.35 / +0.30%
Today’s Change
92.28
Today|||52-Week Range
150.75
+11.00%
Year-to-Date

Today’s Trading

Previous close116.50
Today’s open116.41
Day’s range115.84 - 118.31
Volume64,681
Average volume (3 months)101,377
Market cap$4.8B
Dividend yield--
Data as of 4:02pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+11.67%
Earnings growth (this year)-8.55%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+10.18%
P/E ratio--
Price/Sales6.45
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.54+1.16%
ALNYAlnylam Pharmaceutic...+0.83+1.57%
OPKOPKO Health Inc-0.06-0.77%
AGNPRAAllergan plc+3.01+0.35%
Data as of 4:02pm ET, 04/28/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$950.8M
Annual profit (last year)$540.9M
Net profit margin56.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts